DiscoverABCs of NMOSD301. Pediatric NMOSD | Part II, Treatment & Symptom Management
301. Pediatric NMOSD | Part II, Treatment & Symptom Management

301. Pediatric NMOSD | Part II, Treatment & Symptom Management

Update: 2022-03-07
Share

Description

Rebecca Whitney of SRNA was joined by Drs. Jayne Ness and Silvia Tenembaum for an ABCs of NMOSD podcast titled, “Pediatric NMOSD - Part II, Treatment and Symptom Management.” The experts began by explaining symptoms of pediatric NMOSD. They discussed acute and ongoing treatments, considerations (including vaccines), side-effects, and whether or not aquaporin-4 antibody levels are continuously monitored. The experts also compared and contrasted NMOSD and MOGAD in children. Finally, they provided information on long-term symptom management, repeated MRIs, and indications of a relapse that would require emergency medical care.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

301. Pediatric NMOSD | Part II, Treatment & Symptom Management

301. Pediatric NMOSD | Part II, Treatment & Symptom Management

Siegel Rare Neuroimmune Association (SRNA)